FDA Approves First Device for Asherman Syndrome, Addressing Infertility
FDA approves Womed Leaf, the first medical device for Asherman syndrome, which affects 20-45% of women after uterine procedures and causes infertility.
US News
FDA approves Womed Leaf, the first medical device for Asherman syndrome, which affects 20-45% of women after uterine procedures and causes infertility.